1971-S AMH MARS BLAC 233

SHB 1971 - H AMD 227

By Representative Marshall

WITHDRAWN 03/08/2025

On page 2, beginning on line 20, after "levels" strike all material through "include" on line 21 and insert ", including"

On page 2, after line 33, insert the following:

"NEW SECTION. Sec. 3. A new section is added to chapter 74.09 RCW to read as follows:

(1) The authority shall require that any prescription hormone therapy covered by medical assistance programs established under this chapter provide reimbursement for a 12-month refill of covered prescription hormone therapy obtained at one time by the enrollee, unless the enrollee requests a smaller supply, the prescribing provider instructs that the enrollee must receive a smaller supply, or the prescription hormone therapy is a controlled substance. If the prescription hormone therapy is a controlled substance, the authority must require reimbursement for the maximum refill allowed under state and federal law to be obtained at one time by the enrollee. Any dispensing practices required by the authority must follow clinical guidelines for appropriate prescribing and dispensing to ensure the health of the patient while maximizing access to effective prescription hormone therapy.

(2) Nothing in this section prohibits a prescribing provider from temporarily limiting refills that may be obtained to a 90-day supply at one time if the prescription hormone therapy is experiencing an acute dispensing shortage provided limits must be rescinded at first opportunity of a regularly reinstated, sustainable supply.

(3) For purposes of this section, "prescription hormone therapy" means all drugs approved by the United States food and drug administration that are used to medically suppress, increase, or replace hormones that the body is not producing at intended levels, including glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists."

--- END ---